高血压患者心肌声学密度与基质金属蛋白酶9及组织抑制因子1的关系

山东大学学报(医学版)

高血压患者心肌声学密度与基质金属蛋白酶9及组织抑制因子1的关系

张艳敏，杜乃立，杜瑞芝，郝恩魁

山东大学附属济南市中心医院心内科，济南 250013

收稿日期:2008-02-21 修回日期:1900-01-01 出版日期:2008-11-16 发布日期:2008-11-16
通讯作者: 杜乃立

Relationship between myocardial acoustic densitometry and matrix metalloproteinase in essential hypertensive patients

ZHANG Yan-min,　DU Nai-li，　DU Rui-zhi,　HAO En-kui

Department of Cardiology， Jinan Central Hospital Affiliated to Shandong University， Jinan 250013， China

Received:2008-02-21 Revised:1900-01-01 Online:2008-11-16 Published:2008-11-16
Contact: DU Rui-zhi

摘要/Abstract

摘要： 目的观察原发性高血压患者心肌声学密度（AD）和血清基质金属蛋白酶9（MMP-9）及基质金属蛋白酶组织抑制因子1（TIMP-1）含量的变化，评估其对高血压心肌纤维化的诊断价值，并探讨二者之间的关系。方法选择原发性高血压患者72例，根据左心室质量指数分成心肌肥厚组（40例）和心肌非肥厚组（32例）。健康查体者30例作为正常对照组。采用AD技术测量室间隔矫正的声学强度（CAI1）及背向散射积分周期变化值（CVIB1）、左室后壁矫正的声学强度（CAI2）及背向散射积分周期变化值（CVIB2），酶联免疫法检测血清MMP-9及TIMP-1浓度。结果高血压心肌肥厚组的CAI1和CAI2值均高于心肌非肥厚组及对照组（P＜0.01)，其CVIB1和CVIB2值均低于心肌非肥厚组及对照组（P＜0.01），其血清MMP9及TIMP1浓度均高于心肌非肥厚组及对照组（P＜0.01)，但其二者比值较其他两组降低（P＜0.05）；心肌肥厚组的血清MMP-9与心肌CAI1和CAI2值呈正相关（P＜0.01），与CVIB1和CVIB2值呈负相关（P＜0.01），TIMP1与心肌CAI1和CAI2值呈正相关（P＜0.01）。结论高血压患者心肌声学密度定量指标与血清MMP-9和TIMP-1浓度存在相关性，二者均可用于评估高血压心肌纤维化的严重程度。

关键词: 明胶酶B, 高血压, 心肌声学密度

Abstract: To evaluate the clinical value of quantitative myocardial acoustic densitometry in myocardial fibrosis in relative to an alteration in serum metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) concentrations in essential hypertensive patients. Methods72 essential hypertensive patients were divided into two groups based on the left ventricular mass index: 40 patients with left ventricular hypertrophy(the LVH group) and 32 patients without left ventricular hypertrophy(the NLVH group), and 30 normal persons served as healthy controls. Calibrated acoustic intensity in the septal(CAl1)　and posterior wall(CAI2) and cyclic variation of integrated backscatter in the septal(CVIB1)and posterior wall(CVIB2) were determined by the AD technique． Concentrations of MMP-9 and TIMP-1 were determined by enzyme-linked immunosorbent assays (ELISA). ResultsCAI1 and CAI2 in the LVH group(46.12±4.52 and 45.84±5.71, respectively) were significantly higher than those in the NLVH group (41.61±5.98 and 41.42±5.62, respectively) and the control group (38.30±3.87 and 37.18±3.88, respectively)(P＜0.01). However, CVIB1 and CVIB2 in the LVH group(7.19±1.27 and 8.99±1.35, respectively) were significantly lower than those in the NLVH group (8.59±1.89 and 10.23±1.80, respectively) and the control group (9.29±2.11 and 10.92±2.10, respectively)(P＜0.01). MMP-9 and TIMP-1 concentrations in the LVH group (32.75±4.95 and 83.21±32.65, respectively) were significantly higher than those in the NLVH group(28.20±5.70 and 60.09±28.51,respectively) and the control group (25.26±5.97 and 38.18±10.61, respectively)(P＜0.01)， while the MMP-9/TIMP-1 ratio in the LVH group (0.46±0.24) was significantly lower than that in the NLVH group (0.57±0.21) and the control group (0.69±0.19) (P＜0.05). MMP-9 level in the LVH group was positively related to CAI1 and CAI2(0.71 and 0.78, respectively)(P＜0.01), which was inversely related to CVIB1 and CVIB2(-0.80 and -0.70, respectively)(P＜0.01). Also the TIMP-1 level in the LVH group was positively related to CAI1 and CAI2(0.79 and 0.80, respectively)(P＜0.01). ConclusionMyocardial acoustic densitometry parameters are significantly related to MMP-9 and TIMP-1, which may be potentially used for evaluation of severity of myocardial fibrosis.

Key words: Myocardial acoustic densitometry, Hypertension, Gelatinase B

中图分类号:

R544.1

张艳敏,杜乃立,杜瑞芝,郝恩魁. 高血压患者心肌声学密度与基质金属蛋白酶9及组织抑制因子1的关系[J]. 山东大学学报(医学版), 2008, 46(11): 1045-1048.

ZHANG Yan-min,DU Nai-li,DU Rui-zhi,HAO En-kui.

Relationship between myocardial acoustic densitometry and matrix metalloproteinase in essential hypertensive patients

[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(11): 1045-1048.

参考文献

相关文章 15

[1]	吴逸南葛志明李方贺红姜虹张运. 自发性高血压大鼠肾脏血管紧张素转换酶2的表达[J]. 山东大学学报(医学版), 2209, 47(6): 5-.
[2]	于涛,刘焕乐,冯新,徐付印,陈亚飞,薛付忠,张成琪. 基于健康管理队列的高血压风险预测模型[J]. 山东大学学报（医学版）, 2017, 55(6): 61-65.
[3]	严芳英,单晓兰,李静媛,张杰,闫雪芳,杨奕,卜培莉. 吡格列酮通过调控Sirt3改善高血压引起的心肌纤维化机制[J]. 山东大学学报（医学版）, 2017, 55(5): 13-18.
[4]	李睿,马伟红,任满意,赵萌萌,姜珊,巨媛媛,郭颖,孙昭辉,隋树建. TWEAK与原发性高血压患者心脏重塑的相关性[J]. 山东大学学报（医学版）, 2017, 55(5): 49-55.
[5]	王维军,周宁全,王超. CT定位微创徒手穿刺软通道技术治疗中等量高血压脑出血68例[J]. 山东大学学报（医学版）, 2017, 55(5): 61-65.
[6]	张华,庄霞,刘振东,刁玉涛,杜佳晨,崔谊. 磁共振弥散张量成像技术评价高血压对年轻成年人脑白质损伤[J]. 山东大学学报（医学版）, 2017, 55(5): 56-60.
[7]	王立轩,张璐,许新,李思雪,刘敏,王亚萍,马慧娟. 慢性间歇性低压低氧通过PI3K依赖的eNOS活化增强大鼠胸主动脉舒张[J]. 山东大学学报（医学版）, 2016, 54(2): 11-15.
[8]	徐忠阳, 王立启, 徐振兴, 赵乾, 朱世明. RhoA/ROCK信号通路与原发性高血压患者血压变异性及颈动脉内膜中层厚度的相关性[J]. 山东大学学报（医学版）, 2015, 53(2): 48-51.
[9]	余慧慧, 雷震, 王淑康, 潘芳. 老年高血压与糖尿病共病患者的不良情绪与相关因素[J]. 山东大学学报（医学版）, 2015, 53(12): 81-85,96.
[10]	张英. 健康教育在128例老年高血压患者临床护理中的应用[J]. 山东大学学报（医学版）, 2014, 52(Z1): 193-194.
[11]	江洪, 刘洪, 黄彩英, 梁烨, 李近都, 卢冠铭, 李天资. 原发性高血压患者miRNA-375表达变化的临床意义[J]. 山东大学学报（医学版）, 2014, 52(S2): 9-10.
[12]	黄晓华, 国庆, 赵艳平, 马良, 王久刚, 斯琴格日乐, 金双龙, 刘艳丽. 蒙西药结合治疗老年性高血压病的疗效观察[J]. 山东大学学报（医学版）, 2014, 52(S2): 13-15.
[13]	崔洪芝. 北京降压O号治疗高血压临床观察[J]. 山东大学学报（医学版）, 2014, 52(S2): 45-45.
[14]	吴修华, 杜杰. 微创颅内血肿清除术治疗高血压脑出血临床观察[J]. 山东大学学报（医学版）, 2014, 52(S2): 84-84.
[15]	何思陆, 陆高翔, 梁烨, 韦彤雁, 李清锋, 李天资, 赖腾芳, 唐习强, 李近都. 富马酸比索洛尔联合野芭蕉治疗腔隙性脑梗塞疗效观察[J]. 山东大学学报（医学版）, 2014, 52(S1): 40-42.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed